Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WHV
|
|||
| Former ID |
DNC003485
|
|||
| Drug Name |
4-Piperidino-Piperidine
|
|||
| Synonyms |
4-Piperidinopiperidine; 4897-50-1; 1,4'-Bipiperidine; 4-PIPERIDINO-PIPERIDINE; 1,4'-Bipiperidyl; 1,4-Bipiperidine; [1,4']BIPIPERIDINYL; 4-(1-piperidinyl)piperidine; 1-(piperidin-4-yl)piperidine; 4-(piperidin-1-yl)piperidine; 4-Piperidino piperidine; 4-piperidin-1-ylpiperidine; 1-(4-PIPERIDYL)PIPERIDINE; CHEMBL174391; CHEBI:40117; QDVBKXJMLILLLB-UHFFFAOYSA-N; N-(4-PIPERIDINO)PIPERIDINE; MFCD00006475; 4-piperidylpiperidine; {1,4'}bipiperidinyl; 4PN; 1,4'-bipiperidin; 4-Piperidinopiperidine, 95%, tech.
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H20N2
|
|||
| Canonical SMILES |
C1CCN(CC1)C2CCNCC2
|
|||
| InChI |
1S/C10H20N2/c1-2-8-12(9-3-1)10-4-6-11-7-5-10/h10-11H,1-9H2
|
|||
| InChIKey |
QDVBKXJMLILLLB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 4897-50-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
824042, 840640, 3136507, 6473911, 7885368, 8199796, 15120425, 24878040, 37630954, 43134161, 46507790, 49742717, 49833185, 53794384, 57332625, 57565989, 57641025, 80771513, 85175923, 87558350, 88811796, 92712325, 103094361, 103153268, 103437728, 104092009, 104370471, 104715948, 117358134, 117523707, 118283870, 123082193, 125351311, 126579210, 126590587, 126607776, 126614541, 126625662, 126656784, 126668915, 126670211, 126696571, 126731272, 126736668, 127983372, 128397303, 129008513, 131270515, 131375375, 135035510
|
|||
| ChEBI ID |
CHEBI:40117
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.